New Issue: RBC sells $1.54 million 8.25% fixed-coupon barrier notes on Moderna

Chicago, March 28 – Royal Bank of Canada priced $1.54 million of 9% fixed-coupon barrier notes due May 3, 2023 tied to the common stock of Moderna, Inc., according to a 424B2 filing with the Securities and Exchange Commission.

Interest is payable monthly.

The payout at maturity will be par unless the stock finishes below its 60% barrier price, in which case investors will be fully exposed to decline.

RBC Capital Markets, LLC is the agent.

Issuer:	Royal Bank of Canada
Issue:	Fixed-coupon barrier notes
Underlying stock:	Moderna, Inc.
Amount:	$1,539,000
Maturity:	May 3, 2023
Coupon:	9% per year, payable monthly
Price:	Par
Payout at maturity:	Par unless stock finishes below barrier level, in which case investors will be fully exposed to decline
Initial price:	$178.68
Barrier level:	$107.21; 60% of initial levels
Pricing date:	April 28, 2021
Settlement date:	April 30, 2021
Agent:	RBC Capital Markets, LLC
Fees:	2.25%
Cusip:	78016EZC4

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.